Dr. Constantinos (Costas) Hadjipanayis, MD, PhD, FACS
[Specialty: Neurosurgery]
Dept. of Neurosurgery, Mount Sinai Union Square, 10 Union Square East, 5th Floor, Suite 5E, NY, NY , New York, New York, 10003, USA21284461192128448383https://www.mountsinai.org/profiles/constantinos-g-hadjipanayisAre you a medical practitioner and know this Doctor/Consultant? If so, please add a review.
Dr. Hadjipanayis is a board-certified neurosurgeon who has devoted his entire career to the treatment of brain tumor patients. He is a Professor in the Departments of Neurosurgery and Oncological Sciences at the Icahn School of Medicine at Mount Sinai. He is the Chairman of Neurosurgery at Mount Sinai Union Square/Beth Israel and also the Director of Neurosurgical Oncology for the Mount Sinai Health System. Dr. Hadjipanayis was recruited from Emory University where he was Director of the Emory Brain Tumor Center and Chief of Neurosurgery at Emory University Hospital Midtown. Dr. Hadjipanayis is considered a leader in the therapy and surgical management of brain and spinal cord tumors and has developed novel therapeutics for brain tumors in his laboratory. He has served as President of the nonprofit Southeastern Brain Tumor Foundation (SBTF) as well as the Georgia Neurosurgical Society. He is an international expert on minimally invasive, neuro-endoscopic procedures to treat disorders in the brain and skull base. He is also an expert with the use of robotic-assisted digital surgical microscopy for removal of brain and skull base tumors. Dr. Hadjipanayis is a member of the American Board of Neurological Surgery (ABNS), American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), AANS/CNS Tumor Section, and the Society of Neuro-Oncology. He is very active in the instruction and education of undergraduates, graduate students, medical students, neurosurgical residents, and fellows. His clinical interests include all types of brain tumors, including gliomas, with use of awake/cortical mapping techniques, fluorescence-guided surgery (FGS), robotic-assisted neurosurgery, laser interstitial thermal therapy (LITT), and virtual simulation approaches. He is an expert on the use of neuro-endoscopy for pituitary tumors and colloid cysts (has one of the largest published series of patients), microsurgery for skull base tumors (acoustic neuromas and meningiomas), spinal cord tumor removal, cranial and spinal radiosurgery (both LINAC and gamma knife radiosurgery), and experimental therapeutics for gliomas. He was the first to use 5-ALA (Gliolan) and perform FGS on a brain tumor patient in the US in 2011. He also led the FDA effort for approval of 5-ALA (Gleolan) in the US for gliomas in June 2017. Most recently, Dr. Hadjipanayis has been leading the development of the first ever 3D voice-controlled, robotic-assisted digital surgical microscope for neurosurgery that was launched with a live surgical broadcast to the annual CNS meeting in San Francisco from NYC on October 21, 2019.